139 related articles for article (PubMed ID: 6521857)
41. Time course of striatal changes induced by 6-hydroxydopamine lesion of the nigrostriatal pathway, as studied by combined evaluation of rotational behaviour and striatal Fos expression.
Labandeira-Garcia JL; Rozas G; Lopez-Martin E; Liste I; Guerra MJ
Exp Brain Res; 1996 Feb; 108(1):69-84. PubMed ID: 8721156
[TBL] [Abstract][Full Text] [Related]
42. Dissociation of the striatal D-2 dopamine receptor from adenylyl cyclase following 6-hydroxydopamine-induced denervation.
Thomas KL; Rose S; Jenner P; Marsden CD
Biochem Pharmacol; 1992 Jul; 44(1):73-82. PubMed ID: 1321630
[TBL] [Abstract][Full Text] [Related]
43. Posture-independent sensorimotor analysis of inter-hemispheric receptor asymmetries in neostriatum.
Schallert T; Upchurch M; Wilcox RE; Vaughn DM
Pharmacol Biochem Behav; 1983 May; 18(5):753-9. PubMed ID: 6407036
[TBL] [Abstract][Full Text] [Related]
44. Transsynaptic effect of an intrastriatal fetal nigral graft on the sensitivity of the substantia nigra pars reticulata to muscimol in the rat.
Gaudin DP; St-Pierre JA; Lavoie B; Bédard PJ
Exp Neurol; 1994 May; 127(1):45-53. PubMed ID: 8200436
[TBL] [Abstract][Full Text] [Related]
45. Activation of striatal dopamine receptors induces pain inhibition in rats.
Lin MT; Wu JJ; Chandra A; Tsay BL
J Neural Transm; 1981; 51(3-4):213-22. PubMed ID: 7288429
[TBL] [Abstract][Full Text] [Related]
46. Dopamine-mediated circling behaviour does not involve the nigro-tectal pathway.
Reavill C; Leigh N; Jenner P; Marsden CD
Exp Brain Res; 1979 Oct; 37(2):309-16. PubMed ID: 315328
[TBL] [Abstract][Full Text] [Related]
47. Nigrostriatal lesion alters neurophysiological responses to selective and nonselective D-1 and D-2 dopamine agonists in rat globus pallidus.
Carlson JH; Bergstrom DA; Demo SD; Walters JR
Synapse; 1990; 5(2):83-93. PubMed ID: 2309160
[TBL] [Abstract][Full Text] [Related]
48. Enhanced GABA function in the angular complex (lateral periaqueductal grey matter and adjacent reticular formation) alters the postural component of striatal- or nigral-derived circling.
Reavill C; Muscatt S; Leigh PN; Jenner P; Marsden CD
Exp Brain Res; 1984; 56(1):1-11. PubMed ID: 6468558
[TBL] [Abstract][Full Text] [Related]
49. Dopamine receptor sensitivity after chronic dopamine agonists. Striatal 3H-spiroperidol binding in mice after chronic administration of high doses of apomorphine, N-n-propylnorapomorphine and dextroamphetamine.
Riffee WH; Wilcox RE; Vaughn DM; Smith RV
Psychopharmacology (Berl); 1982; 77(2):146-9. PubMed ID: 6812131
[TBL] [Abstract][Full Text] [Related]
50. Long-term treatment with lithium prevents the development of dopamine receptor supersensitivity.
Pert A; Rosenblatt JE; Sivit C; Pert CB; Bunney WE
Science; 1978 Jul; 201(4351):171-3. PubMed ID: 566468
[TBL] [Abstract][Full Text] [Related]
51. 7-[3-(4-[2,3-Dimethylphenyl]piperazinyl)propoxy]-2(1H)-quinolinone (OPC-4392), a presynaptic dopamine autoreceptor agonist and postsynaptic D2 receptor antagonist.
Yasuda Y; Kikuchi T; Suzuki S; Tsutsui M; Yamada K; Hiyama T
Life Sci; 1988; 42(20):1941-54. PubMed ID: 3130534
[TBL] [Abstract][Full Text] [Related]
52. Apomorphine-induced inhibition of striatal dopamine release: role of dopaminergic receptors in substantia nigra.
Maggi A; Bruno F; Cattabeni F; Groppetti A; Parenti M; Racagni G
Brain Res; 1978 Apr; 145(1):180-4. PubMed ID: 205324
[No Abstract] [Full Text] [Related]
53. Behavioral and biochemical expression of D1-receptor supersensitivity following SCH 23390 repeated administrations.
Gandolfi O; Roncada P; Dall'Olio R; Montanaro N
Brain Res; 1988 Jul; 455(2):390-3. PubMed ID: 2969768
[TBL] [Abstract][Full Text] [Related]
54. The effects of chronic bromocriptine treatment on behaviour and dopamine receptor binding in the rat striatum.
Traub M; Wagner HR; Hassan M; Jackson-Lewis V; Fahn S
Eur J Pharmacol; 1985 Nov; 118(1-2):147-54. PubMed ID: 3936723
[TBL] [Abstract][Full Text] [Related]
55. Association of dopamine D1 and D2 receptors with specific cellular elements in the basal ganglia of the cat: the uneven topography of dopamine receptors in the striatum is determined by intrinsic striatal cells, not nigrostriatal axons.
Beckstead RM
Neuroscience; 1988 Dec; 27(3):851-63. PubMed ID: 3150855
[TBL] [Abstract][Full Text] [Related]
56. Behavioral/neurophysiological investigation of effects of combining a quinolinic acid entopeduncular lesion with a fetal mesencephalic tissue transplant in striatum of the 6-OHDA hemilesioned rat.
Olds ME; Jacques DB; Kpoyov O
Synapse; 2003 Jul; 49(1):1-11. PubMed ID: 12710010
[TBL] [Abstract][Full Text] [Related]
57. Substantia nigra as an out-put station for striatal dopaminergic responses: role of a GABA-mediated inhibition of pars reticulata neurons.
Di Chiara G; Porceddu ML; Morelli M; Mulas ML; Gessa GL
Naunyn Schmiedebergs Arch Pharmacol; 1979 Mar; 306(2):153-9. PubMed ID: 571967
[TBL] [Abstract][Full Text] [Related]
58. The ACTH-(4-9) analogue ORG 2766 facilitates denervation supersensitivity after a unilateral 6-OHDA lesion of the corpus striatum in rats.
Vos PE; Bluemink GJ; Wolterink G; Van Ree JM
Neuropeptides; 1991 Aug; 19(4):271-9. PubMed ID: 1656311
[TBL] [Abstract][Full Text] [Related]
59. Definition of the in-vivo accumulation of [3H]spiperone in brain using haloperidol and sulpiride to determine functional dopamine receptor occupation.
Chivers JK; Reavill C; Jenner P; Marsden CD
J Pharm Pharmacol; 1988 Sep; 40(9):613-9. PubMed ID: 2907027
[TBL] [Abstract][Full Text] [Related]
60. Dopamine receptor binding enhancement accompanies lesion-induced behavioral supersensitivity.
Creese I; Burt DR; Snyder SH
Science; 1977 Aug; 197(4303):596-8. PubMed ID: 877576
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
